Fri, Apr 17, 2026 Psoriasis, a condition impacting more than a million Britons, may place sufferers and their relatives at ...

Psoriatic arthritis affects around one in five people with psoriasis, according to Psoriasis Association UK. The two key ...

Psoriasis, affecting over a million people across Britain, may put those living with the condition and their family members ...

Psoriasis is a chronic autoimmune condition that speeds up the skin cell cycle, leading to inflammation, scaling, and visible ...

Dr Tina Bhutani explains how new clinical trial data show that adding weight-loss drugs to standard therapy improves outcomes ...

The new report explained that the link between psoriasis and sleep disorders “is likely multifactorial, driven by ...

This approval provides patients with a new generic option for the folate analog metabolic inhibitor, which is used to treat various cancers and autoimmune conditions such as rheumatoid arthritis and ...

Dermatologists share if your workout of choice helps or hurts your psoriasis, and how to adjust your routine to avoid ...

USA: A phase III randomized trial showed that adding a GLP-1 agonist to standard psoriasis treatment significantly improved ...

Alembic Pharmaceuticals secures USFDA approval for generic Methotrexate injection, boosting its oncology portfolio and strengthening its presence in the US generics market.

The psoriasis clinical trial analysis report delivers important insights into ongoing research of 100+ pipeline psoriasis ...

Alembic Pharmaceuticals advanced 2.35% to Rs 752.20 after the company announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug ...